Sex-Related Differences in Outcomes After Endovascular Treatment of Patients With Late-Window Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 6 1 2022
medline: 19 2 2022
entrez: 5 1 2022
Statut: ppublish

Résumé

Sex-related differences exist in many aspects of acute stroke and were mainly investigated in the early time window with conflicting results. However, data regarding sex disparities in late presenters are scarce. Therefore, we sought to investigate differences in outcomes between women and men treated with endovascular treatment in the late time window. Analyses were based on the SOLSTICE Consortium (Selection of Late-Window Stroke for Thrombectomy by Imaging Collateral Extent), which was an individual-patient level analysis of seven trials and registries. Baseline characteristics, 90-day functional independence (modified Rankin Scale score ≤2), mortality, and symptomatic intracranial hemorrhage were compared between women and men. Effect of sex on the association of age and successful reperfusion (final Thrombolysis in Cerebral Infarction 2b-3) with outcomes was assessed using multivariable logistic regression adjusted for age, National Institutes of Health Stroke Scale score, Alberta Stroke Program Early CT Score, time from onset to puncture, occlusion location, intravenous thrombolysis, and successful reperfusion, with interaction terms. Among 608 patients treated with endovascular treatment, 50.5% were women. Women were older than men (median age of 72 versus 68 years, In this multicenter analysis of late patients treated with endovascular treatment, sex was not associated with functional outcome. However, sex influenced the association between age and safety outcomes, with men experiencing worse outcomes with advancing age.

Sections du résumé

BACKGROUND AND PURPOSE
Sex-related differences exist in many aspects of acute stroke and were mainly investigated in the early time window with conflicting results. However, data regarding sex disparities in late presenters are scarce. Therefore, we sought to investigate differences in outcomes between women and men treated with endovascular treatment in the late time window.
METHODS
Analyses were based on the SOLSTICE Consortium (Selection of Late-Window Stroke for Thrombectomy by Imaging Collateral Extent), which was an individual-patient level analysis of seven trials and registries. Baseline characteristics, 90-day functional independence (modified Rankin Scale score ≤2), mortality, and symptomatic intracranial hemorrhage were compared between women and men. Effect of sex on the association of age and successful reperfusion (final Thrombolysis in Cerebral Infarction 2b-3) with outcomes was assessed using multivariable logistic regression adjusted for age, National Institutes of Health Stroke Scale score, Alberta Stroke Program Early CT Score, time from onset to puncture, occlusion location, intravenous thrombolysis, and successful reperfusion, with interaction terms.
RESULTS
Among 608 patients treated with endovascular treatment, 50.5% were women. Women were older than men (median age of 72 versus 68 years,
CONCLUSIONS
In this multicenter analysis of late patients treated with endovascular treatment, sex was not associated with functional outcome. However, sex influenced the association between age and safety outcomes, with men experiencing worse outcomes with advancing age.

Identifiants

pubmed: 34983244
doi: 10.1161/STROKEAHA.121.037127
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-318

Auteurs

Fouzi Bala (F)

Calgary Stroke Program, Department of Clinical Neurosciences and Radiology (F.B., M.G., A.D., M.D.H., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Ilaria Casetta (I)

Clinica Neurologica, University of Ferrara, Italy (I.C.).

Stefania Nannoni (S)

Stroke Center, Neurology Service, Lausanne University Hospital and University of Lausanne, Switzerland (S.N., P.M.).

Darragh Herlihy (D)

Neuroradiology Department (D.H., J.T., S.P., A.H.), Beaumont Hospital, Dublin, Ireland.

Mayank Goyal (M)

Calgary Stroke Program, Department of Clinical Neurosciences and Radiology (F.B., M.G., A.D., M.D.H., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Enrico Fainardi (E)

Neuroradiology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy (E.F.).

Patrik Michel (P)

Stroke Center, Neurology Service, Lausanne University Hospital and University of Lausanne, Switzerland (S.N., P.M.).

John Thornton (J)

Neuroradiology Department (D.H., J.T., S.P., A.H.), Beaumont Hospital, Dublin, Ireland.
Royal College of Surgeons in Ireland, Dublin, Ireland (J.T.).

Sarah Power (S)

Neuroradiology Department (D.H., J.T., S.P., A.H.), Beaumont Hospital, Dublin, Ireland.

Valentina Saia (V)

Stroke Unit, Santa Corona Hospital, Pietra Ligure (SV), Italy (V.S.).

Aidan Hegarty (A)

Neuroradiology Department (D.H., J.T., S.P., A.H.), Beaumont Hospital, Dublin, Ireland.

Giovanni Pracucci (G)

Stroke Unit, Careggi University Hospital, Florence (G.P.).

Andrew Demchuk (A)

Calgary Stroke Program, Department of Clinical Neurosciences and Radiology (F.B., M.G., A.D., M.D.H., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Salvatore Mangiafico (S)

Interventional Neuroradiology Unit, IRCCS Neuromed, Pozzilli (IS), Italy (S.M.).

Karl Boyle (K)

Department of Geriatric and Stroke Medicine (K.B.), Beaumont Hospital, Dublin, Ireland.

Michael D Hill (MD)

Calgary Stroke Program, Department of Clinical Neurosciences and Radiology (F.B., M.G., A.D., M.D.H., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.
Department of Community Health Sciences (M.D.H., A.A., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Danilo Toni (D)

Emergency Department, Stroke Unit, Sapienza University Hospital, Rome, Italy (D.T.).

Sean Murphy (S)

Department of Geriatric and Stroke Medicine, The Mater Misericordiae University Hospital; School of Medicine, Royal College of Surgeons in Ireland; School of Medicine, University College Dublin, Ireland (S.M.).

Ayoola Ademola (A)

Department of Community Health Sciences (M.D.H., A.A., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Beom Joon Kim (BJ)

Department of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea (B.J.K.).

Bijoy K Menon (BK)

Calgary Stroke Program, Department of Clinical Neurosciences and Radiology (F.B., M.G., A.D., M.D.H., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.
Department of Community Health Sciences (M.D.H., A.A., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Mohammed A Almekhlafi (MA)

Calgary Stroke Program, Department of Clinical Neurosciences and Radiology (F.B., M.G., A.D., M.D.H., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.
Department of Community Health Sciences (M.D.H., A.A., B.K.M., M.A.A.), University of Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH